Mycoplasma Testing Market worth $613.49 Million by 2019

The report “Mycoplasma Testing Market by Products (Instruments, Kits & Reagents, Services), Application (Cell Line, Virus, End of Production Cells), Technology (PCR, ELISA, Direct Assay), End User (Cell Banks, Pharmaceutical Companies) - Global Forecast to 2019”, is expected to reach $613.49 Million by 2019 from $340.29 Million in 2014, growing at a CAGR of 12.51% between 2014 and 2019.

Browse 74 market data tables and 103 figures spread through 175 pages and in-depth TOC on “Mycoplasma Testing Market"

Early buyers will receive 10% customization on this report.


Mycoplasma testing market refers to a wide range of assays and services aimed at ensuring the quality and purity of products and raw materials used in the production of biologics for the pharmaceutical and biotech industries. Spending on R&D in life science research and growing biotechnology & pharmaceutical companies for life science research will drive the growth of this market.


This report segments the global mycoplasma testing market by products, technology, applications and end users. The global market product segments included in the report comprises of instruments, kits & reagents and services. The kits & reagents segment is further divided on the basis of type into stains, elimination kits, PCR assays, nucleic acid detection kits, standards & controls and other kits & reagents.


Inquiry before Buying:


The technology segments included in the report includes microbial culture techniques, DNA staining, PCR, ELISA, direct assay, indirect assay and enzymatic methods. The applications included in this report are cell line testing, virus testing, end of production cells testing and other applications. The cell line testing applications had the largest share of the mycoplasma testing market in 2014. The cell line testing applications are expected to one of the fastest growing applications between 2014 and 2019.


On the basis of end users the global market report is segmented into biotechnology and pharmaceutical companies, academic research institutes, cell banks, contract research organizations and other end users.


The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global mycoplasma testing market in 2014. Asia regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increase in biopharmaceutical companies and spending on R&D in life science research from this region.


You can speak To Research Analyst to know more about Report:


The major players in mycoplasma testing market include Merck & Co., Inc. (U.S.), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), Lonza Group Ltd. (Switzerland), Charles River Laboratories International, Inc. (U.S.), Promo Cell GmbH (Germany), Bionique Testing Laboratories, Inc. (U.S.), American Type Culture Collection (U.S.), InvivoGen.(U.S.), Biological Industries Israel Beit Haemek Ltd. (Israel) and others.


Browse Related Reports:

Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019.


Microbiology Testing/Clinical Microbiology Market by Product (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics), Clinical Application (Periodontal Disease, Respiratory Diseases, STD, UTI) & by Industry - Global Forecast to 2019.


About MarketsandMarkets:

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.


M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.


We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.


Subscribe Reports from Healthcare Domain @


Mr. Rohan

1 South Dearborn Street,

21st Floor, Chicago,

Illinois, 60603, United States,

Tel: +1-888-600-6441

Visit MarketsandMarkets Blog @

Connect with us on LinkedIn @